May 19, 2020 / 5:10 AM / 2 months ago

BRIEF-FDA Approves Roche’S Tecentriq As A First-Line Monotherapy For Lung Cancer

May 19 (Reuters) - Roche Holding AG:

* FDA APPROVES ROCHE’S TECENTRIQ AS A FIRST-LINE MONOTHERAPY FOR CERTAIN PEOPLE WITH METASTATIC NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below